CompletedPhase 3

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

United States1,887 participantsStarted 2007-10

Plain-language summary

The purpose of this study is to determine whether the study drug is safe and effective.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Healthy women between 18 and 45 requesting oral contraception. Smokers may not exceed 35 years of age. Exclusion Criteria: \- The use of steroidal oral contraceptives, or any drug that could alter oral contraception metabolism will be prohibited during the study.

What they're measuring

Pearl Index

Timeframe: Up to 1 year

Trial details

NCT IDNCT00567164

SponsorBayer

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2009-11

Results submitted2013-10-07

View on ClinicalTrials.gov More Contraception trials